A doctor has urged patients to proceed with caution when using cannabis during cancer immunotherapy and called for more ...

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to ...

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how ...

New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK ...

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibody-drug conjugate (ADC ...

To meet the requirements for FDA Breakthrough Device Designation, CDx Diagnostics submitted technical and clinical evidence ...

Ipsen said it received European Union approval for its Cabometyx drug for previously treated advanced neuroendocrine tumors. The French pharmaceutical company said late Thursday that the approval was ...

In this video, Nancy U. Lin, MD, discusses curative intent research in HER2-positive metastatic breast cancer.

The best way to combat misdiagnosis among veterans is by practicing proactive patient care. Establishing a National ...